One Health Group Plc

Report Publication Announcement • Nov 29, 2024

National Storage Mechanism | Additional information

RNS Number : 1033O

One Health Group PLC

29 November 2024

29 November 2024

One Health Group PLC

('One Health' or the 'Group')

Update on Timing of Half Year Results

One Health (AQSE: OHGR), an independent provider of free, high quality NHS care for patients referred through 'Patient Choice' for treatment in orthopaedics, spine, general surgery and gynaecology, will announce its Half Year Results for the six months ended 30 September 2024 during December.

This timing update for the release of the Group's half year results reflects the Group's adoption of International Financial Reporting Standards ("IFRS") for the first time in consideration of a potential move to AIM in 2025. Previously, the Group has reported its results under United Kingdom Generally Accepted Accounting Principles (UK GAAP).

The directors of One Health accept responsibility for this announcement.

- Ends -

For further enquiries:

One Health Group PLC	Via Square One Consulting
Derek Bickerstaff, Chairman
Adam Binns, CEO
Panmure Liberum Emma Earl, Will Goode, Mark Rogers, Joshua Borlant, Rupert Dearden	Tel: +44 (0) 20 3100 2000
Square 1 Consulting Limited
David Bick	Tel: +44 (0) 207 929 5599        +44 (0) 7831 381201

Notes to Editors

One Health engages over 100 NHS Consultants who sub-specialise in the various surgeries offered by the Company, through a growing network of community-based outreach clinics and surgical operating locations. One Health continues to deliver strong growth and in the year to March 2024 provided much needed care to 13,266 new patients, through almost 34,000 consultations and over 6,000 surgical procedures. One Health deploys surgeons and anaesthetists that are mostly employed by the NHS, on a subcontracted basis. It currently works with over 100 professionals across 9 independent hospitals and 37 CQC registered outreach clinics. Within these community-based outreach clinics all consultations and post operative physiotherapy is delivered where required, reducing patient inconvenience and excess travel.

One Health's activities are focused on areas where NHS patient needs are under-supplied by the local NHS service, population density is relatively high and the level of private medical insurance or the ability to self-fund is relatively low. One Health has also sought to expand geographically from its Head Office in Sheffield into neighbouring counties, which meet these criteria. Currently, the Company's activities are focused in Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue of over £23m in the year to 31 March 2024 was derived from over 60 NHS commissioning bodies in addition to contracts with local NHS Hospital Trusts to transfer their internal waiting list patients to One Health for quicker treatment.

One Health's business model has focused to date on four main areas: being Orthopaedics, Spine, General Surgery and Gynaecology. The split of inpatient procedures in the year to 31 March 2024 was as follows: Orthopaedics 46% Spine 22% General Surgery 22% Gynaecology 10%.

Spine and orthopaedics are particularly attractive areas for One Health as the Directors believe that they benefit from powerful growth drivers in terms of an ageing demographic, physical inactivity and an increasing proportion of the population being categorised as obese. Within orthopaedics, the most common surgeries performed by One Health are knee and hip replacements.

One Health delivered 6,169 procedures in the year to 31 March 2024 and the Directors expect the Company to deliver significantly more procedures in the year to 31 March 2025.

One Health was admitted to trading on Aquis in November 2022 with the ticker OHGR.AQ.

For additional information please visit https://www.aquis.eu/companies/OHGR

One Health was admitted to trading on Aquis in November 2022 with the ticker OHGR.AQ.  For additional information please visit https://www.aquis.eu/companies/OHGR

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXMZMZMZRDGDZZ